Roundtable on "Anticompetitive Practices of Big Pharma: the response of the Competition Authorities of BRICS+"

The Roundtable "Anticompetitive Practices of Big Pharma: the response of the Competition Authorities of BRICS+" was organised in a Q&A format. Participants answered three question categories from the moderator. The first concern was the main types of anti-competitive practices of the global players in jurisdictions in a state of development, and ways to combat them. The second phrase of discussion addressed the progressive measures of antitrust response to anti-competitive practices, and the curb of innovation in the pharmaceutical industry: how can the antitrust regulator actively help innovation? The third issue was related to the discussion of the preventive measures of antitrust response. The approaches of the BRICS countries' competition authorities to global economic concentration were discussed with this question in mind: how is it best to jointly respond to the challenges of the growing global oligopoly in the field of high-tech pharmaceuticals?

The speakers who participated in the discussion are key international experts in the field of antitrust from Europe and Asia, BRICS countries, and representatives of regulatory authorities. The session was attended by the head of the Federal Antimonopoly Service of Russia, Igor Artemyev, who also made closing remarks at the session.